JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ak, I.
Right arrow Articles by Pauwels, E. K.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ak, I.
Right arrow Articles by Pauwels, E. K.J.
Journal of Nuclear Medicine Vol. 43 No. 2 203-206
© 2002 by Society of Nuclear Medicine


Brief Communications

Labeling of Mixed Leukocytes with 99mTc-HMPAO Causes Severe Chromosomal Aberrations in Lymphocytes

Ilknur Ak, MD1, Erkan Vardereli, MD1, Beyhan Durak, PhD2, Zafer Gülbas, MD3, Nurettin Basaran, MD2, Marcel P.M. Stokkel, PhD4 and Ernest K.J. Pauwels, PhD4

1 Department of Nuclear Medicine, Osmangazi University, Eskisehir, Turkey
2 Department of Medical Genetics, Osmangazi University, Eskisehir, Turkey
3 Department of Hematology, Osmangazi University, Eskisehir, Turkey
4 Department of Radiology, Division of Nuclear Medicine, Leiden University Medical Center, Leiden, The Netherlands

ABSTRACT

99mTc-d,1-hexamethylpropyleneamine oxime (HMPAO) is widely used as a labeling agent for leukocytes in the diagnosis of inflammatory or infectious foci. Cytotoxicity studies have indicated that intracellular labeling of leukocytes with 111In compounds may have severe detrimental effects on the cells. Methods: In this study, the radiotoxic effects on mixed lymphocytes after labeling with 99mTc-HMPAO was investigated using the cytokinesis-blocked micronucleus assay and chromosomal aberration assay. Results: Whereas negligible numbers of chromosome abnormalities were noted in unlabeled lymphocytes, the labeled lymphocytes showed multiple aberrations of various types, including dicentric, tricentric, and fivecentric chromosomes; centric rings; chromosome and chromatid type breaks; and acentric fragments. Conclusion: Heavily aberrant lymphocytes are seen in 99mTc-HMPAO–labeled mixed leukocytes after routine clinical procedures. It is unlikely, however, that this would cause detrimental effects, such as lymphoid malignancy, as these cells would normally be eliminated through apoptosis or phagocytosis.

Key Words: 99mTc-HMPAO • leukocyte labeling • radiation damage • chromosomal aberrations • lymphocytes




This article has been cited by other articles:


Home page
JNMHome page
C. d. L. Vaylet, N. Colas-Linhart, A. Petiet, B. Bok, I. Ak, E. K.J. Pauwels, and A. D. Tates
White Blood Cell Labeling with 99mTc-HMPAO
J. Nucl. Med., April 1, 2003; 44(4): 657 - 658.
[Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2002 by the Society of Nuclear Medicine.